This report aims to provide a comprehensive presentation of the global market for Digital Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Medicine.
The Digital Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Digital Medicine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Digital Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
2Morrow
Ginger
Akili
Livongo
AliveCor
WellDoc
Mocacare
Proteus
Voluntis
Omada
Segment by Type
Mobile Health
EMR/EHR
Telehealth
Wireless Health
Segment by Application
Diabetes
Mental Health
Heart Disease
Smoking
Drug Non-adherence
Obesity
COPD
Asthma
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Digital Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Digital Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Digital Medicine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Digital Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
2Morrow
Ginger
Akili
Livongo
AliveCor
WellDoc
Mocacare
Proteus
Voluntis
Omada
Segment by Type
Mobile Health
EMR/EHR
Telehealth
Wireless Health
Segment by Application
Diabetes
Mental Health
Heart Disease
Smoking
Drug Non-adherence
Obesity
COPD
Asthma
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Digital Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Mobile Health
1.2.3 EMR/EHR
1.2.4 Telehealth
1.2.5 Wireless Health
1.3 Market by Application
1.3.1 Global Digital Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diabetes
1.3.3 Mental Health
1.3.4 Heart Disease
1.3.5 Smoking
1.3.6 Drug Non-adherence
1.3.7 Obesity
1.3.8 COPD
1.3.9 Asthma
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digital Medicine Market Perspective (2018-2029)
2.2 Digital Medicine Growth Trends by Region
2.2.1 Global Digital Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Digital Medicine Historic Market Size by Region (2018-2023)
2.2.3 Digital Medicine Forecasted Market Size by Region (2024-2029)
2.3 Digital Medicine Market Dynamics
2.3.1 Digital Medicine Industry Trends
2.3.2 Digital Medicine Market Drivers
2.3.3 Digital Medicine Market Challenges
2.3.4 Digital Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Digital Medicine Players by Revenue
3.1.1 Global Top Digital Medicine Players by Revenue (2018-2023)
3.1.2 Global Digital Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Digital Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Digital Medicine Revenue
3.4 Global Digital Medicine Market Concentration Ratio
3.4.1 Global Digital Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Medicine Revenue in 2022
3.5 Digital Medicine Key Players Head office and Area Served
3.6 Key Players Digital Medicine Product Solution and Service
3.7 Date of Enter into Digital Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Digital Medicine Breakdown Data by Type
4.1 Global Digital Medicine Historic Market Size by Type (2018-2023)
4.2 Global Digital Medicine Forecasted Market Size by Type (2024-2029)
5 Digital Medicine Breakdown Data by Application
5.1 Global Digital Medicine Historic Market Size by Application (2018-2023)
5.2 Global Digital Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Digital Medicine Market Size (2018-2029)
6.2 North America Digital Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Digital Medicine Market Size by Country (2018-2023)
6.4 North America Digital Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Digital Medicine Market Size (2018-2029)
7.2 Europe Digital Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Digital Medicine Market Size by Country (2018-2023)
7.4 Europe Digital Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Digital Medicine Market Size (2018-2029)
8.2 Asia-Pacific Digital Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Digital Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Digital Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Digital Medicine Market Size (2018-2029)
9.2 Latin America Digital Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Digital Medicine Market Size by Country (2018-2023)
9.4 Latin America Digital Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Digital Medicine Market Size (2018-2029)
10.2 Middle East & Africa Digital Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Digital Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Digital Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 2Morrow
11.1.1 2Morrow Company Detail
11.1.2 2Morrow Business Overview
11.1.3 2Morrow Digital Medicine Introduction
11.1.4 2Morrow Revenue in Digital Medicine Business (2018-2023)
11.1.5 2Morrow Recent Development
11.2 Ginger
11.2.1 Ginger Company Detail
11.2.2 Ginger Business Overview
11.2.3 Ginger Digital Medicine Introduction
11.2.4 Ginger Revenue in Digital Medicine Business (2018-2023)
11.2.5 Ginger Recent Development
11.3 Akili
11.3.1 Akili Company Detail
11.3.2 Akili Business Overview
11.3.3 Akili Digital Medicine Introduction
11.3.4 Akili Revenue in Digital Medicine Business (2018-2023)
11.3.5 Akili Recent Development
11.4 Livongo
11.4.1 Livongo Company Detail
11.4.2 Livongo Business Overview
11.4.3 Livongo Digital Medicine Introduction
11.4.4 Livongo Revenue in Digital Medicine Business (2018-2023)
11.4.5 Livongo Recent Development
11.5 AliveCor
11.5.1 AliveCor Company Detail
11.5.2 AliveCor Business Overview
11.5.3 AliveCor Digital Medicine Introduction
11.5.4 AliveCor Revenue in Digital Medicine Business (2018-2023)
11.5.5 AliveCor Recent Development
11.6 WellDoc
11.6.1 WellDoc Company Detail
11.6.2 WellDoc Business Overview
11.6.3 WellDoc Digital Medicine Introduction
11.6.4 WellDoc Revenue in Digital Medicine Business (2018-2023)
11.6.5 WellDoc Recent Development
11.7 Mocacare
11.7.1 Mocacare Company Detail
11.7.2 Mocacare Business Overview
11.7.3 Mocacare Digital Medicine Introduction
11.7.4 Mocacare Revenue in Digital Medicine Business (2018-2023)
11.7.5 Mocacare Recent Development
11.8 Proteus
11.8.1 Proteus Company Detail
11.8.2 Proteus Business Overview
11.8.3 Proteus Digital Medicine Introduction
11.8.4 Proteus Revenue in Digital Medicine Business (2018-2023)
11.8.5 Proteus Recent Development
11.9 Voluntis
11.9.1 Voluntis Company Detail
11.9.2 Voluntis Business Overview
11.9.3 Voluntis Digital Medicine Introduction
11.9.4 Voluntis Revenue in Digital Medicine Business (2018-2023)
11.9.5 Voluntis Recent Development
11.10 Omada
11.10.1 Omada Company Detail
11.10.2 Omada Business Overview
11.10.3 Omada Digital Medicine Introduction
11.10.4 Omada Revenue in Digital Medicine Business (2018-2023)
11.10.5 Omada Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Mobile Health
1.2.3 EMR/EHR
1.2.4 Telehealth
1.2.5 Wireless Health
1.3 Market by Application
1.3.1 Global Digital Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diabetes
1.3.3 Mental Health
1.3.4 Heart Disease
1.3.5 Smoking
1.3.6 Drug Non-adherence
1.3.7 Obesity
1.3.8 COPD
1.3.9 Asthma
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digital Medicine Market Perspective (2018-2029)
2.2 Digital Medicine Growth Trends by Region
2.2.1 Global Digital Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Digital Medicine Historic Market Size by Region (2018-2023)
2.2.3 Digital Medicine Forecasted Market Size by Region (2024-2029)
2.3 Digital Medicine Market Dynamics
2.3.1 Digital Medicine Industry Trends
2.3.2 Digital Medicine Market Drivers
2.3.3 Digital Medicine Market Challenges
2.3.4 Digital Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Digital Medicine Players by Revenue
3.1.1 Global Top Digital Medicine Players by Revenue (2018-2023)
3.1.2 Global Digital Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Digital Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Digital Medicine Revenue
3.4 Global Digital Medicine Market Concentration Ratio
3.4.1 Global Digital Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Medicine Revenue in 2022
3.5 Digital Medicine Key Players Head office and Area Served
3.6 Key Players Digital Medicine Product Solution and Service
3.7 Date of Enter into Digital Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Digital Medicine Breakdown Data by Type
4.1 Global Digital Medicine Historic Market Size by Type (2018-2023)
4.2 Global Digital Medicine Forecasted Market Size by Type (2024-2029)
5 Digital Medicine Breakdown Data by Application
5.1 Global Digital Medicine Historic Market Size by Application (2018-2023)
5.2 Global Digital Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Digital Medicine Market Size (2018-2029)
6.2 North America Digital Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Digital Medicine Market Size by Country (2018-2023)
6.4 North America Digital Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Digital Medicine Market Size (2018-2029)
7.2 Europe Digital Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Digital Medicine Market Size by Country (2018-2023)
7.4 Europe Digital Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Digital Medicine Market Size (2018-2029)
8.2 Asia-Pacific Digital Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Digital Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Digital Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Digital Medicine Market Size (2018-2029)
9.2 Latin America Digital Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Digital Medicine Market Size by Country (2018-2023)
9.4 Latin America Digital Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Digital Medicine Market Size (2018-2029)
10.2 Middle East & Africa Digital Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Digital Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Digital Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 2Morrow
11.1.1 2Morrow Company Detail
11.1.2 2Morrow Business Overview
11.1.3 2Morrow Digital Medicine Introduction
11.1.4 2Morrow Revenue in Digital Medicine Business (2018-2023)
11.1.5 2Morrow Recent Development
11.2 Ginger
11.2.1 Ginger Company Detail
11.2.2 Ginger Business Overview
11.2.3 Ginger Digital Medicine Introduction
11.2.4 Ginger Revenue in Digital Medicine Business (2018-2023)
11.2.5 Ginger Recent Development
11.3 Akili
11.3.1 Akili Company Detail
11.3.2 Akili Business Overview
11.3.3 Akili Digital Medicine Introduction
11.3.4 Akili Revenue in Digital Medicine Business (2018-2023)
11.3.5 Akili Recent Development
11.4 Livongo
11.4.1 Livongo Company Detail
11.4.2 Livongo Business Overview
11.4.3 Livongo Digital Medicine Introduction
11.4.4 Livongo Revenue in Digital Medicine Business (2018-2023)
11.4.5 Livongo Recent Development
11.5 AliveCor
11.5.1 AliveCor Company Detail
11.5.2 AliveCor Business Overview
11.5.3 AliveCor Digital Medicine Introduction
11.5.4 AliveCor Revenue in Digital Medicine Business (2018-2023)
11.5.5 AliveCor Recent Development
11.6 WellDoc
11.6.1 WellDoc Company Detail
11.6.2 WellDoc Business Overview
11.6.3 WellDoc Digital Medicine Introduction
11.6.4 WellDoc Revenue in Digital Medicine Business (2018-2023)
11.6.5 WellDoc Recent Development
11.7 Mocacare
11.7.1 Mocacare Company Detail
11.7.2 Mocacare Business Overview
11.7.3 Mocacare Digital Medicine Introduction
11.7.4 Mocacare Revenue in Digital Medicine Business (2018-2023)
11.7.5 Mocacare Recent Development
11.8 Proteus
11.8.1 Proteus Company Detail
11.8.2 Proteus Business Overview
11.8.3 Proteus Digital Medicine Introduction
11.8.4 Proteus Revenue in Digital Medicine Business (2018-2023)
11.8.5 Proteus Recent Development
11.9 Voluntis
11.9.1 Voluntis Company Detail
11.9.2 Voluntis Business Overview
11.9.3 Voluntis Digital Medicine Introduction
11.9.4 Voluntis Revenue in Digital Medicine Business (2018-2023)
11.9.5 Voluntis Recent Development
11.10 Omada
11.10.1 Omada Company Detail
11.10.2 Omada Business Overview
11.10.3 Omada Digital Medicine Introduction
11.10.4 Omada Revenue in Digital Medicine Business (2018-2023)
11.10.5 Omada Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Research Methodology
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.